Sector: MedicalGPC Biotech AG (NASDAQ: GPCB)
Headlines
- CORRECT: GPC Biotch 4Q Losses EUR0.32/Share Vs EUR0.51
Mar 27, 2008 02:08 AM | GPCB
- Calling A Bottom
Jan 24, 2008 10:46 AM | AAUK, ADLR, BPOP, CSIQ, CTXS, EBAY
- Looking For Stability & Support
Nov 12, 2007 10:41 AM | ARAY, ASTI, BCS, BHP, COGN, CREE
- Mixed Open Ahead of Bernanke
Nov 08, 2007 10:16 AM | AAUK, ACAS, AIG, AKNS, AMKR, ARAY
- Pre-Market - Thursday July 26th
Jul 26, 2007 05:52 PM | AAPL, AEIS, AFOP, AGP, AKAM, ARMHY
- EUROPE MARKETS: Europe Stocks Up On Oil Fall, $5.6 Billion Schwarz Pharma Deal
Sep 25, 2006 12:00 PM | AES, GPCB, SRA, WOS
- EUROPE MARKETS: Europe Stocks Up On Oil Fall, $5.6 Billion Schwarz Pharma Deal
Sep 25, 2006 07:00 AM | AES, GPCB, SRA, WOS
- New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACR
Apr 21, 2009 10:27 AM | GPC, GPCB
- GPC Biotech to Hold Meeting and Conference Call on March 25, 2009 to Discuss Year-End 2008 Financial Results
Mar 18, 2009 05:42 AM | GPC, GPCB
- Safety and Overall Survival Data in Docetaxel-Refractory Patients Enrolled in the Satraplatin SPARC Trial Being Presented at 2009 ASCO Genitourinary Cancers Symposium
Feb 27, 2009 04:05 AM | GPC, GPCB
- GPC Biotech and Agennix Announce Proposed Merger
Feb 17, 2009 08:31 PM | GPC, GPCB
- GPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with Advanced Solid Tumors
Dec 09, 2008 04:10 AM | GPC, GPCB
- GPC Biotech Announces Presentation of New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor at the American Society of Hematology Annual Meeting
Dec 08, 2008 04:08 AM | GPC, GPCB
- GPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008
Nov 13, 2008 01:40 AM | GPC, GPCB
- GPC Biotech Schedules Conference Call on November 13th to Discuss Third Quarter 2008 Financial Results
Nov 11, 2008 04:40 AM | GPC, GPCB
- GPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New York
Nov 06, 2008 09:43 AM | GPC, GPCB
- GPC Biotech Presents New Pre-Clinical Data on RGB-286638 Broad-Spectrum Kinase Inhibitor at EORTC-NCI-AACR Meeting
Oct 27, 2008 04:30 AM | GPC, GPCB
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
GPCB
|
Compare to S&P
|
| YTD |
-25.99 %
|
-5.22 %
|
| 4 Weeks |
4.73 %
|
19.68 %
|
| 12 Weeks |
-5.12 %
|
8.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 3.57 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: 486.81 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
